Aarhus University Seal / Aarhus Universitets segl

Association of asthma diagnosis and medication use with fecundability: A prospective cohort study

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review


Purpose: Asthma has been positively associated with irregular menses and infertility in some studies, but data are limited on the relation between asthma medication use and fecundability (i. e., average per-cycle probability of conception among non-contracepting couples). This study examines the extent to which a history of asthma, asthma medication use, and age at first asthma diagnosis are associated with fecundability among female pregnancy planners. Participants and Methods: Pregnancy Study Online (PRESTO) is an ongoing, web-based preconception cohort study of couples aged 21–45 years from North America. Between July 2013 and July 2019, a total of 10,436 participants enrolled in PRESTO, and 8286 were included in the present analysis. At study enrollment, women reported whether they had ever been diagnosed with asthma and, if so, the year they were first diagnosed. Women who reported ever being diagnosed with asthma were asked about medication use, including medication type and frequency of use. Participants completed follow-up questionnaires every 8 weeks for up to 12 months or until pregnancy. Proportional probabilities regression models were used to estimate fecundability ratios (FRs) and 95% confidence intervals (CIs), adjusting for potential confoun-ders. Fecundability ratios below 1.00 indicate reduced probability of conception. Results: There was little association between a history of asthma diagnosis or asthma medication use and fecundability. Compared with no history of asthma, the FR for ever-diagnosis of asthma with medication use was 1.02 (95% CI: 0.91–1.15) and for ever-diagnosis of asthma without medication use was 1.00 (95% CI: 0.91–1.09). Highest intensity asthma medication use (daily plus extra dosing for symptoms), combination inhaled corticosteroid and long-acting beta-agonist inhaler use, and a first diagnosis of asthma after age 17 years were associated with small reductions in fecundability. Conclusion: The present study provides little evidence that asthma or asthma medication use is adversely associated with fecundability.

Original languageEnglish
JournalClinical epidemiology
Pages (from-to)579-587
Number of pages9
Publication statusPublished - Jun 2020

    Research areas

  • Beta agonist, Corticosteroid, Fertility, Time to pregnancy

See relations at Aarhus University Citationformats

ID: 190606051